National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

This is happening at the same time as a broader ban on all external communication by the NIH and other agencies that fall under Health and Human Services through Feb. 1. The NIH is the biggest ...

"Procurement, contracting, traveling and hiring at NIH are continuing for anything directly related to human safety, human or animal healthcare, security, biosafety, biosecurity and IT security ...

Last week, many scientists expressed alarm that the Trump administration had suspended most operations at NIH, which provides grants for scientific research at universities across the country.

WASHINGTON — The National Institutes of Health’s myriad divisions can start new work on mission-critical research, and continue working on ongoing studies, but cannot publicly communicate ...

Say what you want about Bronny James and whether he deserved to get drafted by the Lakers on his own merit, but this is an extremely mature young man who is easy to root for and is, oh by the way ...

Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his opposition to Covid-19 vaccine mandates — make him more of an outsider at the agency.

Scientists are on edge following the Jan. 22 cancellation of multiple meetings with the US National Institutes of Health (NIH). There’s no tally of how many meetings were cancelled, but some ...

The meeting was abruptly canceled Wednesday in a terse email from an NIH staff member; I soon heard from colleagues that all such committees, and other related meetings in the grant process that ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. The Trump ...

More broadly, uncertainty about when meetings will resume and a lack of communication from NIH leadership is fueling fears about the longer-term impact on medical and biotechnology innovation in ...